https://www.selleckchem.com/products/nx-5948.html
Technical success was achieved in all cases. Perioperative mortality was observed in 1 (3%) patient and perioperative complications in 2 (6%). During the follow-up were reported 2 symptoms recurrence; a significant ABI increase (0.57; IQR0.41-0.47 vs. 0.69; IQR0.50-0.67; P 0.01); 1 (3%) major and 2 (6%) minor amputations. Estimated 24 months survival, primary patency, secondary patency, and freedom from restenosis were 97%, 96.9%, 100%, and 93.8% respectively. In this prospective study, the use of the Luminor® (iVascular) was safe
Like
Comment
Share
